AI‑enabled electronic mesh guides the maturation and coordination of lab‑grown islet cells, offering a potential new path toward future diabetes therapies.

The data showed older people had less time from when elevated p-tau217 appeared until they began having symptoms compared to younger ones.

Researchers aimed at clarifying the mechanism underlying this connection and tracking the fate of glucose in hypoxic animals.

Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.

The offering includes the full integration of the ADC technology platform, which will now be offered by Lonza as part of its advanced synthesis portfolio.

On this episode of GEN Live, we deliver a full debrief on the news from AGBT—critical to understanding where NGS, spatial, single-cell, and multiomics are headed.

Jim Tananbaum, MD, Foresite Capital’s founder and CEO, and Michael Rome, PhD, the managing director who leads the firm’s therapeutics investing practice, discuss the firm’s approach to nurturing ...

Researchers say study results provide a clear rationale for developing therapies that target LCN2 in lung cancer patients.

According to data shared during SLAS, the platform was instrumental in helping BellBrook Labs identify 13 novel inhibitors of the protein.

A UCLA study found that macrophages rely on interferon gamma signaling from past infections to preserve innate defenses.

Product-focused roadmap shows how MSC secretomes can become scalable, standardized, GMP-ready biotherapeutics.

Researchers say AI can help biologics manufacturers quantify and optimize the carbon footprint of production operations.